Eli Lilly's experimental pill has shown potential in helping with obesity, with some trials indicating it could replace GLP-1 obesity shots. The pill has hit its goal in a phase 3 trial and may be headed for a quick FDA review, with possible approval by the end of the year. However, there are also concerns and uncertainties surrounding the pill's potency and effects, with some people reportedly losing too much weight.